Lori-AnnFisher JamaicaUniversity of the West Indies, Mona

Institution

Day 1 - Sunday April 14, 2024

Time	Session

09:00 10:30	APOL1 Targeted Therapies: Who to Test and Which Disease to Treat? SK100 Fatiu AbiolaArogundade Chairperson fatiu3@yahoo.comNigeriaObafemi Awolowo University Teaching Hospitals Complex/ National Postgraduate Medical College of Nigeria FernandaSales Luiz Vianna Chairperson fslvianna@gmail.comBrazilUniversidade Federal do Rio Grande do Sul OpeyemiOlabisi Chairperson opeyemi.olabisi@duke.eduUnited StatesDuke University School of Medicine Ethical Aspects of Race-based Genetic Testing AnaIltis Speaker iltisas@wfu.eduUnited StatesWake Forest University Contribution of ApoL1 Risk Genotype to HIVAN SaraladeviNaicker Speaker Saraladevi.Naicker@wits.ac.zaSouth AfricaUniversity of the Witwatersrand Contribution of APOL1 Risk Alleles to Kidney Disease in West Africa DwomoaAdu Speaker dwoms@blueyonder.co.ukGhanaUniversity of Ghana Medical School Targeting ApoL1: A 12-Year Journey from Genetic Discovery to Phase 2 Trials OgoEgbuna Speaker ogo_egbuna@vrtx.comUnited StatesVertex Pharmaceuticals Inc Q and A Hall C2
11:00 12:00	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) PL2 AgnesFogo Chairperson United States GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology My Story VictoriaGray Speaker vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture Obiageli EuniceNnodu Speaker oennodu@gmail.comNigeriaUniversity of Abuja Hall A
16:30 17:30	Policy and Advocacy Approaches BKH02 Lori-AnnFisher Chairperson JamaicaUniversity of the West Indies, Mona MarcelloTonelli Chairperson CanadaUniversity of Calgary Universal Health Coverage for Kidney Diseases: Feasibility, Barriers, and Opportunities for Improving Global Kidney Health VivekanandJha Speaker IndiaGeorge Institute for Global Health India The Role of Kidney Health Advocacy Organizations in Reducing the Global Burden of Kidney Diseases ValerieLuyckx Speaker valerie.luyckx@uzh.chSwitzerlandUniversity of Zurich A Case for National Prevention Programs to Manage CKD IkechiOkpechi Speaker CanadaUniversity of Alberta Q and A Hall A